|
|
|
ATRA Forecast
Recent ATRA Price |
|
ATRA Forecast Price |
$0.00 |
NA% |
$0.00 |
As of
Recent ATRA Analyst Ratings Breakdown |
|
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
Strong buy ratings: |
|
|
|
|
Buy ratings: |
|
|
|
|
Hold ratings: |
|
|
|
|
Sell ratings: |
|
|
|
|
Strong sell ratings: |
|
|
|
|
Average rating: |
|
|
|
|
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
For the Atara Biotherapeutics Inc forecast (traded under symbol ATRA) for one year forward price target at the top of this page, we have presented the average ATRA forecast for forward target price across the analysts covering ATRA, as reported in
data provided by Zacks Investment Research via Quandl.com.
Meanwhile, note that the
median ATRA forecast price target (median being the middle where half of analysts had a higher ATRA forecast and half had a lower ATRA forecast, which is a different metric than the average or mean) was $ as of , while the
highest ATRA forecast in the analyst group was $, and the lowest ATRA forecast in the analyst group was
$, with a standard deviation of $. Get the latest Zacks research report on ATRA — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Name: |
Atara Biotherapeutics Inc |
Website: |
www.atarabio.com |
Sector: |
Biotechnology |
Number of ETFs Holding ATRA: |
15 (see which ones) |
Total Market Value Held by ETFs: |
$6,098,002 |
Total Market Capitalization: |
$73,000,000 |
% of Market Cap. Held by ETFs: |
8.35% |
|
|
|
|
Quotes delayed 20 minutes
|
Hold (2.00 out of 4)
2nd percentile
|
|
|